These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3939152)

  • 61. A cost-benefit analysis of a routine varicella vaccination program for United States Air Force Academy cadets.
    Burnham BR; Wells TS; Riddle JR
    Mil Med; 1998 Sep; 163(9):631-4. PubMed ID: 9753992
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [What is cost benefit analysis?].
    Pedersen KM; Alban A; Danneskiold-Samsøe B
    Ugeskr Laeger; 1990 Jan; 152(1):10-6. PubMed ID: 2105000
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs.
    Hinman AR; Koplan JP
    JAMA; 1984 Jun; 251(23):3109-13. PubMed ID: 6427489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The cost of childhood chickenpox: parents' perspective.
    Lieu TA; Black SB; Rieser N; Ray P; Lewis EM; Shinefield HR
    Pediatr Infect Dis J; 1994 Mar; 13(3):173-7. PubMed ID: 8177622
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An economic analysis of varicella vaccination for health care workers.
    Gray AM; Fenn P; Weinberg J; Miller E; McGuire A
    Epidemiol Infect; 1997 Oct; 119(2):209-20. PubMed ID: 9363019
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Health and Economic Impact of the United States Varicella Vaccination Program, 1996-2020.
    Zhou F; Leung J; Marin M; Dooling KL; Anderson TC; Ortega-Sanchez IR
    J Infect Dis; 2022 Oct; 226(Suppl 4):S463-S469. PubMed ID: 36265847
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The cost-effectiveness of varicella screening and vaccination in U.S. Army recruits.
    Howell MR; Lee T; Gaydos CA; Nang RN
    Mil Med; 2000 Apr; 165(4):309-15. PubMed ID: 10803008
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methods for risk-benefit and cost-benefit analysis of vaccinations.
    Wiedermann G; Ambrosch F
    Dev Biol Stand; 1979; 43():429-32. PubMed ID: 118070
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vaccine finance resources for physicians.
    Sobczyk E
    Pediatrics; 2009 Dec; 124 Suppl 5():S573-6. PubMed ID: 19948594
    [No Abstract]   [Full Text] [Related]  

  • 70. Costs and benefits of measles vaccination in Finland.
    Ekblom M; Elo O; Laurinkari J; Niemelä P
    Scand J Soc Med; 1978; 6(3):111-5. PubMed ID: 103198
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cost-effectiveness analysis of routine immunization for varicella in Japan].
    Sugawara T; Ohkusa Y; Oikawa K; Haneda N; Kikuchi K; Kato F; Yamaguchi S; Okabe N
    Kansenshogaku Zasshi; 2006 May; 80(3):212-9. PubMed ID: 16780127
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Costs and benefits of a second measles inoculation of children in Israel, the West Bank, and Gaza.
    Ginsberg GM; Tulchinsky TH
    J Epidemiol Community Health; 1990 Dec; 44(4):274-80. PubMed ID: 2126028
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Economic evaluation of different chickenpox vaccination strategies].
    Deng X; He H; Zhou Y; Pan J; Yan R; Tang X; Fu J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 47(4):374-380. PubMed ID: 30511524
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Benefits, risks and costs of immunization programmes.
    Koplan JP
    Ciba Found Symp; 1985; 110():55-68. PubMed ID: 3921321
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunization to prevent insulin-dependent diabetes mellitus? The economics of genetic screening and vaccination for diabetes.
    England WL; Roberts SD
    Ann Intern Med; 1981 Mar; 94(3):395-400. PubMed ID: 6784628
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country.
    Beutels P; Gay NJ
    Epidemiol Infect; 2003 Apr; 130(2):273-83. PubMed ID: 12729196
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment.
    Adler MW; Belsey EM; McCutchan JA; Mindel A
    Br Med J (Clin Res Ed); 1983 May; 286(6378):1621-4. PubMed ID: 6405916
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-benefit analysis of vaccine programs.
    Hocking B
    J Occup Med; 1992 Apr; 34(4):357-8. PubMed ID: 1564574
    [No Abstract]   [Full Text] [Related]  

  • 79. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective.
    Edmunds WJ; Medley GF; Nokes DJ
    Stat Med; 1999 Dec; 18(23):3263-82. PubMed ID: 10602150
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Systematic vaccination against chickenpox: benefits and controversies].
    Creusvaux H
    Arch Pediatr; 1996; 3 Suppl 1():332s-333s. PubMed ID: 8796063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.